Literature DB >> 10803678

Relationship between NAT1 genotype and phenotype in a Japanese population.

M Yang1, T Katoh, R Delongchamp, S Ozawa, K Kohshi, T Kawamoto.   

Abstract

NAT1, which biotransforms many carcinogens, is genetically polymorphic. This polymorphism has been postulated as a mechanism for susceptibility differences in cancer, possibly due to NAT1 activity differences. However, the relationship between NAT1 genotype and phenotype is not clear. In our study of 110 Japanese, the frequency of the NAT1*10 allele (0.53, 95% confidence interval 0.46-0.59) was higher than others have observed in Caucasians (0.16). From genotype frequency studies, 26.4% of the subjects belonged to the NAT1*10/*10 genotype, 53.6% to the NAT1*4/*10 genotype and 20% to the NAT1*4/*4 genotype. Neither NAT1*3 nor NAT1*11 genotype was seen in these subjects. In female subjects, we found higher NAT1 activity in NAT1*4/*10 subjects than in NAT1*4/*4 subjects (n = 49; 2.63 versus 2.16 nmol/min/mg protein). NAT1 activity-difference between NAT1*4/*10 and NAT1*10/*10 was not statistically significant. Thus, not only the presence of NAT1*10 allele, but also other factors are suspected of increasing NAT1 activities. After full sequencing of 10 subjects, five individuals having the highest activities and five individuals having the lowest activities, we found NAT1*18A and NAT1*18B to be in the high activity group and the low activity group, respectively. The genotypes containing these variants were heterozygous, i.e. NAT1*4/*18A and NAT1*4/*18B. Due to rare frequencies of these variants, they cannot be considered as other effective, genetic factors on NAT1 activity. Age and tobacco smoking did not affect the relationship between NAT1 genotype and phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803678     DOI: 10.1097/00008571-200004000-00003

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  7 in total

1.  Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study.

Authors:  Sangita Sharma; Xia Cao; Lynne R Wilkens; Jennifer Yamamoto; Annette Lum-Jones; Brian E Henderson; Laurence N Kolonel; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

2.  Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations.

Authors:  Holly M Mortensen; Alain Froment; Godfrey Lema; Jean-Marie Bodo; Muntaser Ibrahim; Thomas B Nyambo; Sabah A Omar; Sarah A Tishkoff
Journal:  Pharmacogenomics       Date:  2011-10-13       Impact factor: 2.533

3.  Carcinogen metabolism, cigarette smoking, and breast cancer risk: a Bayes model averaging approach.

Authors:  Nadine Stephenson; Lars Beckmann; Jenny Chang-Claude
Journal:  Epidemiol Perspect Innov       Date:  2010-11-16

4.  Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population.

Authors:  Veerapol Kukongviriyapan; Auemduan Prawan; Benjamart Warasiha; Wichittra Tassaneyakul; Jareerat Aiemsa-ard
Journal:  Eur J Clin Pharmacol       Date:  2003-07-19       Impact factor: 2.953

5.  Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma.

Authors:  Yawei Zhang; Silvia De Sanjose; Paige M Bracci; Lindsay M Morton; Rong Wang; Paul Brennan; Patricia Hartge; Paolo Boffetta; Nikolaus Becker; Marc Maynadie; Lenka Foretova; Pierluigi Cocco; Anthony Staines; Theodore Holford; Elizabeth A Holly; Alexandra Nieters; Yolanda Benavente; Leslie Bernstein; Shelia Hoar Zahm; Tongzhang Zheng
Journal:  Am J Epidemiol       Date:  2008-04-11       Impact factor: 4.897

Review 6.  Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.

Authors:  L M Bull; D L White; M Bray; Z Nurgalieva; H B El-Serag
Journal:  Dis Esophagus       Date:  2009-02-13       Impact factor: 3.429

7.  Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.

Authors:  Masahide Koda; Motoki Iwasaki; Yuko Yamano; Xi Lu; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2017-10-24       Impact factor: 3.674

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.